Gerald Kay Estate Edward - 20 Mar 2023 Form 3 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Reporting relationship
10%+ Owner
Issuer ticker
INBP
Reported as of
20 Mar 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
16 Nov 2023, 13:49:12 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christina Kay

Key filing fact

Gerald Kay Estate Edward filed Form 3 for INTEGRATED BIOPHARMA INC (INBP) on 16 Nov 2023.

Key facts

  • This page summarizes Gerald Kay Estate Edward's Form 3 filing for INTEGRATED BIOPHARMA INC (INBP).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 16 Nov 2023, 13:49.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,293,815
Date
20 Mar 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INBP holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
150,000
Exercise price
$0.2300
Footnotes
F2
INBP holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
66,667
Exercise price
$0.7200
Footnotes
F2
INBP holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,667
Exercise price
$1.04
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 819,628 shares currently registered in the name of EGK LLC, an entity Mr. E Gerald Kay was the sole member of.

Footnote F2

Acquired upon the passing of E Gerald Kay, the former President and Executive Chairman of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .